Which of the following statements is/are correct of Covaxin ?

(i) Covaxin is India’s indigenous Covid 19 Vaccine.

(ii) It is an Intranasal Vaccine.

(iii) It is developed by Serum Institute.

Question

Question

This question was previously asked in

Kerala PSC Common Preliminary Exam (GRADUATE LEVEL) PYP - 096/21

Answer 1

The correct answer is Only (i).

Key Points

Covaxin is India's indigenous Covid-19 vaccine developed by Bharat Biotech.
It is an inactivated vaccine developed using Whole-Virion Inactivated Vero Cell technology.
Covaxin has been approved for emergency use in India and several other countries.
It was developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).

Important Points

Covaxin has shown efficacy against Covid-19 variants, including Delta, according to clinical studies.
It requires two doses administered 28 days apart for full efficacy.
Bharat Biotech has also worked on expanding production facilities to meet demand.

Additional Information

Option (ii): Covaxin is not an intranasal vaccine. Intranasal vaccines are administered through the nose, and Bharat Biotech has developed a separate intranasal vaccine called iNCOVACC.
Option (iii): Covaxin is not developed by Serum Institute of India. The Serum Institute is responsible for producing Covishield, another Covid-19 vaccine developed by AstraZeneca and Oxford University.
Intranasal Vaccines: These types of vaccines are designed to be administered through the nasal route and are considered beneficial for their ease of administration and ability to induce mucosal immunity.
Serum Institute of India: A leading vaccine manufacturer based in Pune, India, known for producing Covishield, which has been widely used for Covid-19 immunization globally.